Genomics|Update|Non Communicable Diseases ► CANCER

Genomics|Update|Non Communicable Diseases

Volume 34  Number 19  May 14-21, 2015

Cancer

BRCAPRO 6.0 model validation in male patients presenting for BRCA testing. 
Mitri ZI et al. Oncologist 2015 May 6.

Childhood cancers in families with and without Lynch syndrome. 
Heath JA et al. Fam. Cancer 2015 May 12.

Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy. 
Whitney DH et al. BMC Med Genomics 2015 May 6. 8(1) 18

Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making. 
Weiss GJ et al. Onco Targets Ther 2015 8959-67

Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D). 
Vasen HF et al. J. Med. Genet. 2014 May 51(5) 283-93

Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: A cost-effectiveness analysis.
Gallego CJ, et al. J Clin Oncol. 2015 May 4. pii: JCO.2014.59.3665.

RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers. 
Boleij A et al. Oncotarget 2015 Apr 12.

[Recommendation for genetic testing in patients suffering from gynecological malignancy]. 
Zikán M et al. Ceska Gynekol 2015 80(2) 97-103

Screening for breast cancer by molecular testing for three founder mutations in the BRCA1 and BRCA2 genes among women of Ashkenazi Jewish heritage. 
Palomaki GE et al. J Med Screen 2015 May 5.

Survival in familial colorectal cancer: a Danish cohort study. 
Lautrup CK et al. Fam. Cancer 2015 May 12.

Understanding breast cancer subtypes, by Laura Martin, Cure Today, May 12

FDA approves Roche KRAS mutation test for metastatic colorectal cancer patients, Genome Web, May 11 [by free subscription only] 

MicroRNA and cancer therapeutics, by Alexa Lim, Science Friday, May 8